top of page
Screenshot 2024-12-12 at 2.23.53 PM.png
blue-macro-eye-close-260nw-1914725293_edited copy.jpg

REVOLUTIONARY
immune-profiling technology. 

TRANSFORMATIONAL SOLUTIONS THROUGH PRECISION IMMUNOTHERAPY

At Feromics, our mission-focused team of scientists, engineers, and clinicians reflects our commitment to transforming the future of immunotherapy and delivering groundbreaking therapies. Our solutions include novel drug candidates, proprietary cutting-edge single-cell technologies, and collaborative research initiatives that drive innovation and deliver real assets.

Solutions

DATA DRIVEN, ASSET FOCUSED.

IMMUNOTHERAPY

  • Uncover molecular pathways driving immune cell cytotoxicity and functionality to advance CAR-T and CAR-Treg therapies.

  • Applications:

       — Develop and optimize CAR-T constructs to enhance

           efficacy and persistence.

       — Develop and optimize CAR-Treg constructs for

           immune modulation to suppress overactive immune

          responses in autoimmune diseases.

PRECISION MEDICINE

  • Derisk preclinical and clinical development: optimize efficacy and patient outcomes through personalized immune profiling.

  • Donor selection: optimize allogeneic immunotherapies by selecting high efficacy donors.

  • Personalized immunotherapy: select an immunotherapy based on the patient’s immune profile.

R & D

REVOLUTIONARY

While others attempt to decipher omics data from functionally heterogenous immune cells, leveraging AI 

tools to find value in an omics soup of functional phenotypes. Feromics developed a revolutionary biotechnology and workflow that accurately identifies, isolates, and analyzes unique immune cell phenotypes associated with a specific disease, allowing us to maximize the potential of AI tools to identify actionable, high confidence data for the design novel immunotherapies.

  • Oncology

  • Immunology

Platform

INNOVATIVE TECHNOLOGY & WORKFLOW

Bringing an engineering bottom-up discovery workflow, our Intelligent Design™ platform of single-cell assays accurately identifies, isolates, and analyzes unique immune cell phenotypes associated with a specific disease to produce our proprietary omics data. These unique datasets power our AI-driven bioinformatics, unlock functional immunomics to decode immune cell heterogeneity. Backed by our mission-focused team of scientists, engineers, and clinicians, Feromics offers a robust, asset-focused drug discovery and development laboratory designed to accelerate innovation and deliver impactful results in immunotherapy and precision medicine.

Strategy

LEADING THE WAY IN PRECISION IMMUNOTHERAPY

Our strategic approach is designed to drive innovation through actionable data and informed decision making to deliver proven results in cancer and autoimmune disease treatments. Our commitment to science, collaboration, and patient-centric care underpins every aspect of our strategy. 

Screenshot 2025-01-14 at 9.12.39 AM.png

PIPELINE

Feromics is actively applying its Intelligent Design platform toward the development of new therapies.

PROGRAM

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

Diffuse large B-cell lymphoma (DLBCL)

F01-50 ID-CAR-T

Undisclosed indication

F03-50 ID-CAR-T

bottom of page